Comparison · NSE · data 2026-11-02
Alembic Pharmaceuticals Limited vs PFIZER LIMITED
In plain words
Size: PFIZER LIMITED is about 1.1 times the market value of Alembic Pharmaceuticals Limited.
Return on equity: PFIZER LIMITED 17.2% vs Alembic Pharmaceuticals Limited 12.3%.
Profit growth over 3 years: Alembic Pharmaceuticals Limited 25.4% a year vs PFIZER LIMITED 5% a year.
Debt to equity: Alembic Pharmaceuticals Limited 0.25 vs PFIZER LIMITED 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| APLLTD | PFIZER | |
|---|---|---|
| Price | ₹804.6 | ₹3,630.6 |
| Market cap | ₹15,682 cr | ₹16,867 cr |
| P/E | 22.8 | 22.6 |
| P/B | — | — |
| ROE | 12.3% | 17.2% |
| ROCE | 11.8% | 20.0% |
| Debt / equity | 0.25 | 0.02 |
| Operating margin | 10.6% | 34.4% |
| Dividend yield | 1.50% | 2.03% |
| Sales growth, 3 years (yearly) | 9.0% | 1.3% |
| Profit growth, 3 years (yearly) | 25.4% | 5.0% |
| 1-year return | -10.6% | -31.8% |
| Revenue, last 12 months | ₹7,784 cr | ₹2,570 cr |
| Net profit, last 12 months | ₹693 cr | ₹735 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹173 cr | ₹204 cr |
| Quarter profit vs a year earlier | +12.1% | +6.6% |
| Promoter holding | 69.87% | 63.92% |
| Health check | Strong (6.9/10) | Average (6/10) |
Common questions
Which has a higher P/E, Alembic Pharmaceuticals Limited or PFIZER LIMITED?
Alembic Pharmaceuticals Limited trades at the higher P/E (22.8 against 22.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
PFIZER LIMITED (17.2% against 12.3%).
Which carries more debt?
Alembic Pharmaceuticals Limited has the higher debt-to-equity ratio (0.25 against 0.02).